The science of presenting the value proposition to those who evaluate the cost effectiveness of a drug, device or medication - we work with internationally respected opinion leaders to manage the best outcomes for drugs.
Increasingly, these cost evaluations are based on facts rather than traditional prescribing habits.
Omega has valuable experience managing market access at all stages of the product lifecycle, including:
- Pricing research
- Payer research
- Health economic evaluation and ‘research in real world studies
- Negotiations with national authorities
- Medical writing
- Writing value propositions and value dossiers
- Training and materials for market access teams